pricing model and weighted-average grant date fair value for options granted in 2024, 2023, and 2022 are as follows:
The total intrinsic value of options exercised, representing the difference between the exercise price and the market price on the date of exercise, was approximately $
45
million, $
28
million, and $
41
million in 2024, 2023, and 2022, respectively.
Transactions related to stock options for the fiscal year ended January 31, 2025, are summarized as follows:
1
Includes outstanding vested options as well as outstanding nonvested options after a forfeiture rate is applied.
Restricted Stock Awards
Restricted stock awards are valued at the market price of a share of the Company’s common stock on the date of grant.  In general, these awards vest ratably over a
three-year
period from the date of grant.  Certain awards vest
50
% at the end of a
two-
Table of Contents
year
period from the date of grant and
50
% at the end of a
three-year
period from the date of grant, or vest
100
% at the end of a
three-year
period from the date of grant.  All awards are expensed on a straight-line basis over a
three-year
period, which is considered to be the requisite service period.  The Company uses historical data to estimate the timing and amount of forfeitures.  The weighted-average grant-date fair value per share of restricted stock awards granted was $
249.31
,
$
201.78
, and
$
201.10
in 2024, 2023, and 2022, respectively.  The total fair value of restricted stock awards vesting each year was approximately $
158
million, $
208
million, and $
203
million in 2024, 2023, and 2022, respectively.
Transactions related to restricted stock awards for the fiscal year ended January 31, 2025, are summarized as follows:
Deferred Stock Units
Deferred stock units are valued at the market price of a share of the Company’s common stock on the date of grant and earn dividend equivalents.  For non-employee Directors, these awards vest on the earlier of the first anniversary of the grant date and the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances, and are expensed on a straight-line basis over the requisite service period.  Awards granted prior to 2022 vested immediately and were expensed on the grant date.
Deferred stock units granted to non-employee Directors in 2024, 2023, and 2022 are as follows:
Performance Share Units
The Company issues performance share units classified as equity awards.  Expense is recognized on a straight-line basis over the requisite service period, based on the probability of achieving the performance condition, with changes in expectations recognized as an adjustment to earnings in the period of the change.  Compensation cost is not recognized for performance share units that do not vest because service or performance conditions are not satisfied, and any previously recognized compensation cost is reversed.  Performance share units do not have dividend rights.  The